Search for other papers by Xueren Gao in
Current site
Google Scholar
PubMed
Search for other papers by Yuqing Chen in
Current site
Google Scholar
PubMed
Abstract
Previous observational studies have investigated the association between urinary albumin excretion and the risk of colorectal cancer (CRC), but the results have been inconsistent. This study aimed to explore the causal association between urine albumin-to-creatinine ratio (ACR) and CRC risk through a two-sample Mendelian randomization (MR) analysis. The genome-wide association study (GWAS) data of ACR (n = 382,500) and CRC (CRC: 6,509 cases and 287,137 controls) were obtained from the IEU OpenGWAS project website and the FinnGen database, respectively. The TwoSampleMR and MR-PRESSO R packages were used to search for and analyze genetic variations that served as instrumental variables for ACR. The odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated using the inverse-variance weighted method, MR-Egger, and weighted median. Genetically predicted ACR was not associated with CRC risk (all P > 0.05). Further analysis based on the site of onset (colon or rectum) also did not show a significant association (all P > 0.05). MR-PRESSO, MR-Egger regression and leave-one-out sensitivity analysis all indicated that the current results were robust and reliable. These findings suggest that ACR does not affect CRC risk and may not be used as a marker of CRC risk in clinical practice. However, relevant studies especially in ethnically diverse populations are still needed to confirm the current findings.
-
1.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71(3): 209–49. https://doi.org/10.3322/caac.21660.
-
2.
Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol 2021; 14(2): 89–103. https://doi.org/10.5114/pg.2018.81072.
-
3.
Dobrowolski P, Januszewicz A, Gumprecht J, Małyszko J, Narkiewicz K, Stompór T, et al. Why albuminuria should be assessed more frequently in everyday clinical practice? A position statement. Pol Arch Intern Med 2021; 131(4): 396–406. https://doi.org/10.20452/pamw.15874.
-
4.
Mok Y, Ballew SH, Sang Y, Coresh J, Joshu CE, Platz EA, et al. Albuminuria, kidney function, and cancer risk in the Community. Am J Epidemiol 2020; 189(9): 942–50. https://doi.org/10.1093/aje/kwaa043.
-
5.
Kanbay M, Copur S, Yilmaz ZY, Tanriover C, Hasbal NB, Ortiz A, et al. A novel risk factor for malignancy: albuminuria. Eur J Intern Med 2023; 118: 22–31. https://doi.org/10.1016/j.ejim.2023.09.010.
-
6.
Ahn SY, Choi YJ, Han K, Ko GJ, Kwon YJ, Park YG. Dipstick proteinuria and cancer incidence: a nationwide population-based study. J Nephrol 2020; 33(5): 1067–77. https://doi.org/10.1007/s40620-020-00740-1.
-
7.
Mok Y, Matsushita K, Ballew SH, Sang Y, Jung KJ, Lee S, et al. Kidney function, proteinuria, and cancer incidence: the Korean Heart Study. Am J Kidney Dis 2017; 70(4): 512–21. https://doi.org/10.1053/j.ajkd.2017.03.018.
-
8.
Tu H, Wen CP, Tsai SP, Chow WH, Wen C, Ye Y, et al. Cancer risk associated with chronic diseases and disease markers: prospective cohort study. BMJ 2018; 360: k134. https://doi.org/10.1136/bmj.k134.
-
9.
Jørgensen L, Heuch I, Jenssen T, Jacobsen BK. Association of albuminuria and cancer incidence. J Am Soc Nephrol 2008; 19(5): 992–998. https://doi.org/10.1681/ASN.2007060712.
-
10.
Luo L, Kieneker LM, van der Vegt B, Bakker SJL, Gruppen EG, Casteleijn NF, et al. Urinary albumin excretion and cancer risk: the PREVEND cohort study. Nephrol Dial Transpl 2023; 38(12): 2723–32. https://doi.org/10.1093/ndt/gfad107.
-
11.
Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014; 23(R1): R89–98. https://doi.org/10.1093/hmg/ddu328.
-
12.
Birney E. Mendelian randomization. Cold Spring Harb Perspect Med 2022; 12(4): a041302. https://doi.org/10.1101/cshperspect.a041302.
-
13.
Haas ME, Aragam KG, Emdin CA, Bick AG, International Consortium for Blood Pressure, Hemani G, et al. Genetic association of albuminuria with cardiometabolic disease and blood pressure. Am J Hum Genet 2018; 103(4): 461–73. https://doi.org/10.1016/j.ajhg.2018.08.004.
-
14.
Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 2023; 613(7944): 508–18. https://doi.org/10.1038/s41586-022-05473-8.
-
15.
Levin MG, Judy R, Gill D, Vujkovic M, Verma SS, Bradford Y, et al. Genetics of height and risk of atrial fibrillation: a Mendelian randomization study. Plos Med 2020; 17(10): e1003288. https://doi.org/10.1371/journal.pmed.1003288.
-
16.
Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res 2012; 21(3): 223–42. https://doi.org/10.1177/0962280210394459.
-
17.
Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008; 27(8): 1133–63. https://doi.org/10.1002/sim.3034.
-
18.
Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 2018; 7: e34408. https://doi.org/10.7554/eLife.34408.
-
19.
Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50(5): 693–8. https://doi.org/10.1038/s41588-018-0099-7.
-
20.
Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49(11): 1603–16. https://doi.org/10.1016/j.freeradbiomed.2010.09.006.
-
21.
Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005; 10: 1881–96. https://doi.org/10.2741/1667.
-
22.
Movafagh S, Crook S, Vo K. Regulation of hypoxia-inducible factor-1a by reactive oxygen species: new developments in an old debate. J Cell Biochem 2015; 116(5): 696–703. https://doi.org/10.1002/jcb.25074.
-
23.
Qin Z, Li H, Wang L, Geng J, Yang Q, Su B, et al. Systemic immune- inflammation index is associated with increased urinary abumin excretion: a population-based study. Front Immunol 2022; 13: 863640. https://doi.org/10.3389/fimmu.2022.863640.
-
24.
Upadhyay A, Larson MG, Guo CY, Vasan RS, Lipinska I, O'Donnell CJ, et al. Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transpl 2011; 26(3): 920–6. https://doi.org/10.1093/ndt/gfq471.
-
25.
Fernandez-Fernandez B, Izquierdo MC, Valiño-Rivas L, Nastou D, Sanz AB, Ortiz A, et al. Albumin downregulates Klotho in tubular cells. Nephrol Dial Transpl 2018; 33(10): 1712–22. https://doi.org/10.1093/ndt/gfx376.
-
26.
Kuro-o M. Klotho in health and disease. Curr Opin Nephrol Hypertens 2012; 21(4): 362–8. https://doi.org/10.1097/MNH.0b013e32835422ad.
-
27.
Mencke R, Olauson H, Hillebrands JL. Effects of Klotho on fibrosis and cancer: a renal focus on mechanisms and therapeutic strategies. Adv Drug Deliv Rev 2017; 121: 85–100. https://doi.org/10.1016/j.addr.2017.07.009.
-
28.
Lin Y, Yang Y, Fu T, Lin L, Zhang X, Guo Q, et al. Impairment of kidney function and kidney cancer: a bidirectional Mendelian randomization study. Cancer Med 2023; 12(3): 3610–22. https://doi.org/10.1002/cam4.5204.
Editor-in-Chief
László ROSIVALL (Semmelweis University, Budapest, Hungary)
Managing Editor
Anna BERHIDI (Semmelweis University, Budapest, Hungary)
Co-Editors
- Gábor SZÉNÁSI (Semmelweis University, Budapest, Hungary)
- Ákos KOLLER (Semmelweis University, Budapest, Hungary)
- Zsolt RADÁK (University of Physical Education, Budapest, Hungary)
- László LÉNÁRD (University of Pécs, Hungary)
- Zoltán UNGVÁRI (Semmelweis University, Budapest, Hungary)
Assistant Editors
- Gabriella DÖRNYEI (Semmelweis University, Budapest, Hungary)
- Zsuzsanna MIKLÓS (Semmelweis University, Budapest, Hungary)
- György NÁDASY (Semmelweis University, Budapest, Hungary)
Hungarian Editorial Board
- György BENEDEK (University of Szeged, Hungary)
- Zoltán BENYÓ (Semmelweis University, Budapest, Hungary)
- Mihály BOROS (University of Szeged, Hungary)
- László CSERNOCH (University of Debrecen, Hungary)
- Magdolna DANK (Semmelweis University, Budapest, Hungary)
- László DÉTÁRI (Eötvös Loránd University, Budapest, Hungary)
- Zoltán GIRICZ (Semmelweis University, Budapest, Hungary and Pharmahungary Group, Szeged, Hungary)
- Zoltán HANTOS (Semmelweis University, Budapest and University of Szeged, Hungary)
- Zoltán HEROLD (Semmelweis University, Budapest, Hungary)
- László HUNYADI (Semmelweis University, Budapest, Hungary)
- Gábor JANCSÓ (University of Pécs, Hungary)
- Zoltán KARÁDI (University of Pecs, Hungary)
- Miklós PALKOVITS (Semmelweis University, Budapest, Hungary)
- Gyula PAPP (University of Szeged, Hungary)
- Gábor PAVLIK (University of Physical Education, Budapest, Hungary)
- András SPÄT (Semmelweis University, Budapest, Hungary)
- Gyula SZABÓ (University of Szeged, Hungary)
- Zoltán SZELÉNYI (University of Pécs, Hungary)
- Lajos SZOLLÁR (Semmelweis University, Budapest, Hungary)
- József TOLDI (MTA-SZTE Neuroscience Research Group and University of Szeged, Hungary)
- Árpád TÓSAKI (University of Debrecen, Hungary)
International Editorial Board
- Dragan DJURIC (University of Belgrade, Serbia)
- Christopher H. FRY (University of Bristol, UK)
- Stephen E. GREENWALD (Blizard Institute, Barts and Queen Mary University of London, UK)
- Tibor HORTOBÁGYI (University of Groningen, Netherlands)
- George KUNOS (National Institutes of Health, Bethesda, USA)
- Massoud MAHMOUDIAN (Iran University of Medical Sciences, Tehran, Iran)
- Tadaaki MANO (Gifu University of Medical Science, Japan)
- Luis Gabriel NAVAR (Tulane University School of Medicine, New Orleans, USA)
- Hitoo NISHINO (Nagoya City University, Japan)
- Ole H. PETERSEN (Cardiff University, UK)
- Ulrich POHL (German Centre for Cardiovascular Research and Ludwig-Maximilians-University, Planegg, Germany)
- Andrej A. ROMANOVSKY (University of Arizona, USA)
- Anwar Ali SIDDIQUI (Aga Khan University, Karachi, Pakistan)
- Csaba SZABÓ (University of Fribourg, Switzerland)
- Eric VICAUT (Université de Paris, UMRS 942 INSERM, France)
Editorial Correspondence:
Physiology International
Semmelweis University
Faculty of Medicine, Institute of Translational Medicine
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: pi@semmelweis.hu
Indexing and Abstracting Services:
- Biological Abstracts
- BIOSIS Previews
- CAB Abstracts
- CABELLS Journalytics
- EMBASE/Excerpta Medica
- Global Health
- Index Copernicus
- Index Medicus
- Medline
- Referativnyi Zhurnal
- SCOPUS
- WoS - Science Citation Index Expanded
| 2023 | |
|---|---|
| Web of Science | |
| Journal Impact Factor | 2.2 |
| Rank by Impact Factor | Q3 (Physiology) |
| Journal Citation Indicator | 0.58 |
| Scopus | |
| CiteScore | 3.4 |
| CiteScore rank | Q2 (Physical Therapy, Sports Therapy and Rehabilitation) |
| SNIP | 0.508 |
| Scimago | |
| SJR index | 0.407 |
| SJR Q rank | Q2 |
| Physiology International | |
|---|---|
| Publication Model | Hybrid |
| Submission Fee | none |
| Article Processing Charge | 1100 EUR/article |
| Printed Color Illustrations | 40 EUR (or 10 000 HUF) + VAT / piece |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription fee 2025 | Online subsscription: 752 EUR / 828 USD Print + online subscription: 880 EUR / 968 USD |
| Subscription Information | Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content. |
| Purchase per Title | Individual articles are sold on the displayed price. |
| Physiology International | |
|---|---|
| Language | English |
| Size | B5 |
| Year of Foundation |
2006 (1950) |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Magyar Tudományos Akadémia |
| Founder's Address |
H-1051 Budapest, Hungary, Széchenyi István tér 9. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 2498-602X (Print) |
| ISSN | 2677-0164 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Oct 2024 | 213 | 4 | 6 |
| Nov 2024 | 204 | 6 | 7 |
| Dec 2024 | 121 | 1 | 2 |
| Jan 2025 | 143 | 0 | 0 |
| Feb 2025 | 140 | 0 | 0 |
| Mar 2025 | 87 | 1 | 1 |
| Apr 2025 | 0 | 0 | 0 |
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.